| News

DSM strengthens the Basel Area life sciences cluster

05.11.2020

The global nutrition and health corporation Royal DSM is establishing a new innovation center at the headquarters of Nutritional Products in Kaiseraugst. The Nutrition & Health Campus will be ready in 2023. This gives the Basel Area life sciences cluster a further boost.

The new Nutrition & Health Campus of DSM (Visualization: Nissen Wentzlaff Architekten)

Royal DSM is creating its new Health & Nutrition Campus on the site of Nutritional Products in Kaiseraugst. It will encompass modern research laboratories and collaborative workplaces. Construction is set to begin at the start of 2021 and the building will be ready for use in 2023.

The Campus will bring together more than 200 researchers from the fields of chemicals, formulation, application and analytics. According to a press release, this unites the research & development department with all other innovation activities and business functions to create “the company’s largest global innovation hub”.

When compared with the current situation, which sees employees split across three different buildings, energy consumption for heating will be reduced by 90 percent and electricity use by 80 percent. Transparent bridges will connect the new building and the main existing Nutritional Products global headquarters building. Local landscape designers will be creating a near-natural environment, which will “significantly enhance” the green spaces and biodiversity. The plan is also to incorporate a fully-equipped fitness center for all staff. The campus concept was put together by the Basel office of Nissen Wentzlaff Architekten.

“Our aim is to create a new center of gravity for innovation in the area of nutrition and health, and further strengthen the region in its significance,” commented Thomas Beck, Senior Vice President Innovation. With the construction of the DSM innovation center, the importance of the Basel Area life sciences cluster in particular continues to grow.

The global DSM Nutritional Products Business Group is run out of Kaiseraugst. Local production facilities include manufacturing plants in in Aesch BL, Sisseln AG, Lalden/Visp VS as well as in Baden-Württemberg and in the Alsatian Village-Neuf in the immediate vicinity of Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BLKB supporting startups in Basel region
Basel Area Business & Innovation, Innovation

BLKB supporting startups in Basel region

Basellandschaftliche Kantonalbank (BLKB) has founded the inQbator startup accelerator. Together with its partners Hemex and Launchpad, the bank will be...

Read More
BioVersys receives funding in the fight against tuberculosis
Basel Area Business & Innovation, Invest

BioVersys receives funding in the fight against tuberculosis

The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners. This financing serves to help...

Read More
Biosynex takes up residence in Delémont
Basel Area Business & Innovation, Invest

Biosynex takes up residence in Delémont

The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a test for COVID-19. It has...

Read More
Novartis Campus opening further
Basel Area Business & Innovation, Switzerland Innovation Park

Novartis Campus opening further

Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus. The Switzerland Innovation Park Basel...

Read More
docdok.health increases safety of coronavirus vaccinations
Basel Area Business & Innovation, Innovation

docdok.health increases safety of coronavirus vaccinations

The Basel-based start-up docdok.health has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The...

Read More
Hemex attracts Swiss investors
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Hemex attracts Swiss investors

A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for Hemex. The...

Read More
1 2 3 40

Do you have a question? We'd like to hear from you.